Breast cancer breakthrough as drug cuts risk of most tumour returning by 37%

Breast cancer breakthrough as drug cuts risk of most tumour returning by 37% A revolutionary drug could save the lives of thousands of women battling the most aggressive type of breast cancer, doctors say.

Pembrolizumab cuts the risk of the disease returning by 37 per cent in women with triple-negative breast cancer, a trial showed. The Daily Mail

See also:

• Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer (abstract) New England Journal of Medicine
• Immunity-boosting breast cancer drug could save thousands, finds UK research The Guardian